WTA
TARO

Washington Trust Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Washington Trust Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$8.47K – 687
2024
Q1 		$8.47K Hold
200
– – ﹤0.01% 503
2023
Q4 		$8.36K Hold
200
– – ﹤0.01% 507
2023
Q3 		$7.54K Hold
200
– – ﹤0.01% 504
2023
Q2 		$7.59K Hold
200
– – ﹤0.01% 495
2023
Q1 		$4.86K Hold
200
– – ﹤0.01% 613
2022
Q4 		$5.81K Hold
200
– – ﹤0.01% 580
2022
Q3 		$6K Hold
200
– – ﹤0.01% 700
2022
Q2 		$7K Hold
200
– – ﹤0.01% 699
2022
Q1 		$9K Hold
200
– – ﹤0.01% 730
2021
Q4 		$10K Buy
+200
New +$11.2K ﹤0.01% 744

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Washington Trust Advisors's TARO Position: Q2 2024 in Review

Washington Trust Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 200 shares — an estimated $8.47K sold.

Washington Trust Advisors first reported a position in TARO in Q4 2021 and held it in 10 quarters. The position peaked at $10K in Q4 2021. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Washington Trust Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Washington Trust Advisors sold 200 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $8.47K.
  • Washington Trust Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2021 and held it in 10 quarters.
  • Washington Trust Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $10K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Washington Trust Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.